Attributes | Values |
---|
rdf:type
| |
Description
| - Introduction: Transcatheter aortic valve implantation (TAVI) represents an effective treatment of high-risk patients with severe aortic stenosis. There is no evidence of the long-term outcome of alternative approaches to TAVI. Aim: To asses the clinical outcome after subclavian and aortic TAVI compared to standard femoral approach. Methods: Prospective single-centre study comprise 228 consecutive TAVI patients (average age 79 years, logistic EuroSCORE 17.2, 53.5% females) divided in 1)Femoral, 2)Aortic and 3)Subclavian groups. More peripheral artery disease was found in both Aortic and Subclavian groups. The self-expandable CoreValve (Medtronic Inc., Minneapolis, MN USA) stented prosthesis was exclusively implanted. Results: In 99.6% the valve was successfully deployed. At 30 days the mortality and bleeding occurred in 2.6% and 3.5%, respectively, irrespective of the approach.
- Introduction: Transcatheter aortic valve implantation (TAVI) represents an effective treatment of high-risk patients with severe aortic stenosis. There is no evidence of the long-term outcome of alternative approaches to TAVI. Aim: To asses the clinical outcome after subclavian and aortic TAVI compared to standard femoral approach. Methods: Prospective single-centre study comprise 228 consecutive TAVI patients (average age 79 years, logistic EuroSCORE 17.2, 53.5% females) divided in 1)Femoral, 2)Aortic and 3)Subclavian groups. More peripheral artery disease was found in both Aortic and Subclavian groups. The self-expandable CoreValve (Medtronic Inc., Minneapolis, MN USA) stented prosthesis was exclusively implanted. Results: In 99.6% the valve was successfully deployed. At 30 days the mortality and bleeding occurred in 2.6% and 3.5%, respectively, irrespective of the approach. (en)
|
Title
| - Differences in long-term outcome after femoral, subclavian and aortic approach to transcatheter aortic valve implantation (TAVI)
- Differences in long-term outcome after femoral, subclavian and aortic approach to transcatheter aortic valve implantation (TAVI) (en)
|
skos:prefLabel
| - Differences in long-term outcome after femoral, subclavian and aortic approach to transcatheter aortic valve implantation (TAVI)
- Differences in long-term outcome after femoral, subclavian and aortic approach to transcatheter aortic valve implantation (TAVI) (en)
|
skos:notation
| - RIV/00216224:14110/14:00078124!RIV15-MSM-14110___
|
http://linked.open...avai/riv/aktivita
| |
http://linked.open...avai/riv/aktivity
| |
http://linked.open...iv/cisloPeriodika
| |
http://linked.open...vai/riv/dodaniDat
| |
http://linked.open...aciTvurceVysledku
| |
http://linked.open.../riv/druhVysledku
| |
http://linked.open...iv/duvernostUdaju
| |
http://linked.open...titaPredkladatele
| |
http://linked.open...dnocenehoVysledku
| |
http://linked.open...ai/riv/idVysledku
| - RIV/00216224:14110/14:00078124
|
http://linked.open...riv/jazykVysledku
| |
http://linked.open.../riv/klicovaSlova
| - Aortic valve implantation; Transaortic approach; Long-term mortality; TAVI; Aortic stenosis (en)
|
http://linked.open.../riv/klicoveSlovo
| |
http://linked.open...odStatuVydavatele
| - US - Spojené státy americké
|
http://linked.open...ontrolniKodProRIV
| |
http://linked.open...i/riv/nazevZdroje
| - Experimental & clinical card
|
http://linked.open...in/vavai/riv/obor
| |
http://linked.open...ichTvurcuVysledku
| |
http://linked.open...cetTvurcuVysledku
| |
http://linked.open...UplatneniVysledku
| |
http://linked.open...v/svazekPeriodika
| |
http://linked.open...iv/tvurceVysledku
| - Jarkovský, Jiří
- Kala, Petr
- Blaha, Milan
- Branny, Marian
- Januska, Jaroslav
- Branny, Piotr
- Hudec, Miroslav
- Kluzova, Krystyna
- Kufova, Pavla
- Sknouril, Libor
|
issn
| |
number of pages
| |
http://localhost/t...ganizacniJednotka
| |